home All News open_in_new Full Article
Novartis eleva su beneficio un 29% en el primer semestre de 2025 impulsado por tres medicamentos clave
today 4 w. ago attach_file Politics
attach_file
Politics
attach_file
Politics
attach_file
Politics
attach_file
Politics
attach_file
Politics
attach_file
Politics
attach_file
Politics
attach_file
Politics
attach_file
Politics
attach_file
Politics
attach_file
Politics
attach_file
Politics
attach_file
Politics
attach_file
Politics
attach_file
Politics
attach_file
Politics
ID: 2747613054